AstraZeneca settles £505 million tax dispute with UK
This article was originally published in Scrip
Executive Summary
AstraZeneca has agreed to pay the UK government £505 million to settle a long-running and complex dispute with tax authorities. The resolution was welcomed by investors with midday trading showing a 1% increase in the firm's share price.